glp 1 wirkung GLP-1 Agonists - What is it? GLP-1 | Summary

Description

The risk of developing these severe side effects is very small, but it is important that patients and healthcare professionals are aware and alert to the associated symptoms. An estimated 1.6 million UK adults used GLP-1s such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) to lose weight between early 2024 and early 2025, with an additional 3.3 million interested in using weight loss drugs during 2026

It is therefore important not only to harness the initial boost in motivation to exercise experienced during treatment but also to provide behavioural change support in the weeks and months running up to the end of treatment

Current research provides reassurance: No evidence shows that GLP-1 therapy directly reduces testosterone levels

doi: 10.1200/jco.2008.16.3725 24 RochlinDHBarrioAVMcLaughlinSZee VanKJWoodsJFDayanJHet al

Behavioral changes after starting GLP-1 therapy for weight loss in Chicago Patients in programs like the one offered by Pure Medical Spa see significant GLP-1 behavior changes